CLL1 and CD38 Dual CAR-T

· 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CLL1 and CD38 Dual CAR-T, covering 2025-02-26 to 2025-02-26. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Preliminary Efficacy of CLL1 and CD38 Dual CAR-T in r/r AML [EARLY_Phase 1]